Anthropic, Genmab partner to use Claude for R&D and more digital health news
Anthropic, Genmab partner to use Claude for R&D and more digital health news | MobiHealthNews
Skip to main content…
Continue Reading
Tag: R&D
Mastering the EHR Learning Curve: 2026 Strategies for IT Competency
Chris Mercier, Vice President, R&D, Juno Health
Professionals across public, acute, and behavioral health rely on electronic health record (EHR) software to support patient care and documentation every day. Entering diagnoses, care plans, and administrative…
Continue Reading
Subsense Raises $10M to Replace Brain Implants with Nasal Nanoparticles
What You Should Know:
– Subsense Inc. has raised an additional $10M, bringing its total funding to $27M, to develop a non-surgical brain-computer interface (BCI) that relies on engineered nanoparticles rather than implanted chips.
– Administered…
Continue Reading
Pharma × AI: The End of Pilots and the Rise of Captive AI Boutiques
Thomas Kluz, Managing Director at Niterra Ventures
What if the future of drug discovery no longer rests on bold experiments, but on disciplined partnerships where artificial intelligence becomes as indispensable to pharma as the laboratory…
Continue Reading
South Korea sets $645M medtech R&D plan and more briefs
South Korea sets $645M medtech R&D plan and more briefs | Healthcare IT News
Skip to main content…
Continue Reading
Report: Healthcare AI Adoption is 2.2X Faster Than the Broader Economy
What You Should Know:
– According to the inaugural State of AI in Healthcare Report from Menlo Ventures, AI spending in the sector is surging, reaching $1.4 billion in 2025—nearly tripling last year’s total. Remarkably,…
Continue Reading
Revalia Bio Launches ‘Human Data Trials’ with $14.5M to Transform Drug Development
What You Should Know:
– Revalia Bio Inc., a new pre-clinical research company secures $14.5M in seed funding round to support the launch of its “Human Data Trials”.
– The funding was co-led by America’s Frontier…
Continue Reading
Gates Foundation Commits $2.5B to Women’s Health R&D to Combat Chronic Underfunding
What You Should Know:
– The Gates Foundation announced a $2.5B commitment through 2030 to accelerate research and development (R&D) focused exclusively on women’s health.
– The investment will support the advancement of more than 40…
Continue Reading
Arkstone Acquired by ARCHIMED to Accelerate Global Fight Against Antimicrobial Resistance
What You Should Know:
– Arkstone, a pioneer in machine learning (ML) and artificial intelligence (AI)-driven infectious disease clinical decision support and antimicrobial stewardship has been acquired by ARCHIMED, a private equity firm specializing in…
Continue Reading
Cycle Time is the New Currency of Drug Development
Raj Indupuri, CEO and Co-Founder of eClinical Solutions
For years, the life sciences industry has been trying to address the same R&D challenges: rising costs, patient recruitment and retention, and difficulty maximizing ROI. Drug development is expensive,…
Continue Reading